These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8637180)

  • 41. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mesenteric arterial function in the rat in pregnancy: role of sympathetic and sensory-motor perivascular nerves, endothelium, smooth muscle, nitric oxide and prostaglandins.
    Ralevic V; Burnstock G
    Br J Pharmacol; 1996 Apr; 117(7):1463-70. PubMed ID: 8730740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
    Gradin KA; Li JY; Andersson O; Simonsen U
    J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of sympathetic neurotransmission by neuropeptide Y Y2 receptors in rats and guinea pigs.
    Potter EK; Tripovic D
    Exp Brain Res; 2006 Aug; 173(2):346-52. PubMed ID: 16733694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission.
    Donoso MV; Miranda R; Irarrázaval MJ; Huidobro-Toro JP
    J Vasc Res; 2004; 41(5):387-99. PubMed ID: 15377822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Leu31, Pro34] NPY, a selective functional postjunctional agonist at neuropeptide-Y receptors in anaesthetised rats.
    Potter EK; McCloskey MJ
    Neurosci Lett; 1992 Jan; 134(2):183-6. PubMed ID: 1317023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
    Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
    Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.
    Dietrich P; Moleda L; Kees F; Müller M; Straub RH; Hellerbrand C; Wiest R
    J Hepatol; 2013 Feb; 58(2):254-61. PubMed ID: 23041305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
    Pernow J; Svenberg T; Lundberg JM
    Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors.
    Lew MJ; Murphy R; Angus JA
    Br J Pharmacol; 1996 Apr; 117(8):1768-72. PubMed ID: 8732289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [NPY as a periarterial sympathetic transmitter in isolated vessel].
    Chiba S
    Nihon Yakurigaku Zasshi; 2001 Mar; 117(3):187-94. PubMed ID: 11288488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.
    Lacroix JS; Ulman LG; Potter EK
    Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
    Owen MP
    J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
    Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
    J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
    Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
    Gicquiaux H; Tschöpl M; Doods HN; Bucher B
    Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
    Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
    J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological analysis of functional neurovascular transmission in canine splenic arteries: role of neuropeptide Y.
    Chiba S; Yang XP
    Auton Autacoid Pharmacol; 2002 Aug; 22(4):187-97. PubMed ID: 12656944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre- and postjunctional receptors be distinguished?
    Wahlestedt C; Håkanson R
    Med Biol; 1986; 64(2-3):85-8. PubMed ID: 3018392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.